Discover
TRVI
Trevi Therapeutics, Inc.
18.18
1 x 15.09
1 x 19.50
bid
ask
+
1.41
8.41%
1 @ 04:00 PM
17.90 -0.28 (1.54%)
| Ytd | 45.21% | |
| 1y | 166.57% |
17.01
day range
18.26
6.55
52 week range
20.22
| Open | 17.14 | Prev Close | 16.77 | Low | 17.01 | High | 18.26 | Mkt Cap | 2.58B |
| Vol | 2.21M | Avg Vol | 2.06M | EPS | -0.32 | P/E | -56.81 | Forward P/E | -31.98 |
| Beta | 1.00 | Short Ratio | 6.33 | Inst. Own | 99.22% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-05 | 50-d Avg | 15.85 | 200-d Avg | 12.83 | 1yr Est | 24.90 |
| Income Statement | |||
| Operating Expenses | 14.91M | ||
| Research and Development Expense | 9.94M | ||
| Selling, General and Administrative Expense | 4.97M | ||
| Operating Income | -14.91M | ||
| Income Tax Expense | -20.00K | ||
| Net Income | -13.19M | ||
| Net Income Common Stock | -13.19M | ||
| Net Income Common Stock (USD) | -13.19M | ||
| Consolidated Income | -13.19M | ||
| Earnings per Basic Share | -0.09 | ||
| Earnings per Basic Share (USD) | -0.09 | ||
| Earnings per Diluted Share | -0.09 | ||
| Earning Before Interest & Taxes (EBIT) | -13.21M | ||
| Earning Before Interest & Taxes (USD) | -13.21M | ||
| Weighted Average Shares | 145.59M | ||
| Weighted Average Shares Diluted | 145.59M | ||
| Balance Sheet | |||
| Cash and Equivalents | 19.41M | ||
| Cash and Equivalents (USD) | 19.41M | ||
| Investments | 152.37M | ||
| Investments Current | 152.37M | ||
| Current Assets | 176.12M | ||
| Property, Plant & Equipment Net | 875.00K | ||
| Total Assets | 179.61M | ||
| Debt Current | 318.00K | ||
| Total Debt | 682.00K | ||
| Current Liabilities | 7.12M | ||
| Debt Non-Current | 364.00K | ||
| Total Liabilities | 7.48M | ||
| Accumulated Retained Earnings (Deficit) | -343.00M | ||
| Accumulated Other Comprehensive Income | -190.00K | ||
| Shareholders Equity | 172.13M | ||
| Shareholders Equity (USD) | 172.13M | ||
| Assets Non-Current | 3.49M | ||
| Total Debt (USD) | 682.00K | ||
| Liabilities Non-Current | 364.00K | ||
| Trade and Non-Trade Payables | 2.22M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 34.00K | ||
| Net Cash Flow from Financing | 222.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 498.00K | ||
| Capital Expenditure | -102.00K | ||
| Issuance (Purchase) of Equity Shares | 222.00K | ||
| Net Cash Flow from Investing | 16.97M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 17.07M | ||
| Net Cash Flow from Operations | -16.69M | ||
| Share Based Compensation | 2.19M | ||